Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Stephane De Wit"'
Autor:
Isik S. Johansen, Ashley Roen, Christian Kraef, Raquel Martín-Iguacel, Johannes Nemeth, Lukas Fenner, Robert Zangerle, Josep M. Llibre, Robert F. Miller, Isabelle Suarez, Stephane de Wit, Ferdinand Wit, Christina Mussini, Annalisa Saracino, Diana Canetti, Alain Volny-Anne, Nadine Jaschinski, Bastian Neesgaard, Lene Ryom, Lars Peters, Harmony P. Garges, James F. Rooney, Daria Podlekareva, Amanda Mocroft, Ole Kirk
Publikováno v:
International Journal of Infectious Diseases, Vol 147, Iss , Pp 107199- (2024)
Objectives: Tuberculosis (TB) risk after initiation of antiretroviral treatment (ART) is not well described in a European setting, with an average TB incidence of 25/105 in the background population. Methods: We included all adult persons with HIV st
Externí odkaz:
https://doaj.org/article/80a8a55132eb428cb6e9883d32cae885
Autor:
Myron J. Levin, Andrew Ustianowski, Stephane De Wit, Rohini Beavon, Jesse Thissen, Seth Seegobin, Kanika Dey, Karen A. Near, Katie Streicher, Alexandre Kiazand, Mark T. Esser
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1253-1268 (2024)
Abstract Introduction The phase 3 PROVENT and STORM CHASER studies evaluated AZD7442 (tixagevimab/cilgavimab) for pre-exposure and post-exposure prophylaxis of symptomatic coronavirus disease 2019 (COVID-19). We report the final 15-month results of b
Externí odkaz:
https://doaj.org/article/a0dc96dc6a4541d2935ee2e82a120a9f
Autor:
Alessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, Bastian Neesgaard, Stephane De Wit, Isik Somuncu Johansen, Simon Edwards, Christoph Stephan, Georgios Adamis, Therese Staub, Alexandra Zagalo, Pere Domingo, Daniel Elbirt, Katharina Kusejko, Johanna Brännström, Dzmitry Paduta, Tatyana Trofimova, Janos Szlavik, Kai Zilmer, Marcello Losso, Veerle Van Eygen, Helen Pai, Jens Lundgren, Amanda Mocroft, for the EuroSIDA Study Group
Publikováno v:
AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-12 (2022)
Abstract Introduction Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods Participants of EuroSIDA were included if they had started a RPV- or an
Externí odkaz:
https://doaj.org/article/52e7fe1dd5e244669b712b449eee7437
Autor:
Camilla Ingrid Hatleberg, Lene Ryom, David Kamara, Stephane De Wit, Matthew Law, Andrew Phillips, Peter Reiss, Antonella D'Arminio Monforte, Amanda Mocroft, Christian Pradier, Ole Kirk, Helen Kovari, Fabrice Bonnet, Wafaa El-Sadr, Jens D. Lundgren, Caroline Sabin
Publikováno v:
EClinicalMedicine, Vol 13, Iss , Pp 91-100 (2019)
Background: Hypertension is a stronger predictor of hemorrhagic than ischemic strokes in the general population. We aimed to identify whether hypertension or other risk factors, including HIV-related factors, differ in their associations with stroke
Externí odkaz:
https://doaj.org/article/dcccd9ed37ad435a898c17dc3749c647
Autor:
Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Huldrych F Günthard, Coca Necsoi, Matthew Law, Cristina Mussini, Antonella Castagna, Antonella d'Arminio Monforte, Christian Pradier, Nikoloz Chkhartisvilli, Juliana Reyes-Uruena, Jörg Janne Vehreschild, Jan-Christian Wasmuth, Anders Sönnerborg, Christoph Stephan, Lauren Greenberg, Josep M Llibre, Alain Volny-Anne, Lars Peters, Annegret Pelchen-Matthews, Vani Vannappagari, Joel Gallant, Armin Rieger, Mike Youle, Dominique Braun, Stephane De Wit, Kathy Petoumenos, Vanni Borghi, Vincenzo Spagnuolo, Tengiz Tsertsvadze, Jens Lundgren, Lene Ryom, RESPOND study group
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243625 (2020)
ObjectivesTo compare virologic and immunologic outcomes of integrase inhibitor (INSTI)-containing, contemporary boosted protease inhibitor (PI/b)-containing and non-nucleotide reverse transcriptase inhibitor (NNRTI)-containing regimens in a real-life
Externí odkaz:
https://doaj.org/article/99aecc943a9f4f78a422f19e7b5d8586
Autor:
Amina Ait-Ammar, Anna Kula, Gilles Darcis, Roxane Verdikt, Stephane De Wit, Virginie Gautier, Patrick W. G. Mallon, Alessandro Marcello, Olivier Rohr, Carine Van Lint
Publikováno v:
Frontiers in Microbiology, Vol 10 (2020)
One of the most explored therapeutic approaches aimed at eradicating HIV-1 reservoirs is the “shock and kill” strategy which is based on HIV-1 reactivation in latently-infected cells (“shock” phase) while maintaining antiretroviral therapy (A
Externí odkaz:
https://doaj.org/article/0157bc9c5a4343be9f44024c01ba26bf
Autor:
Dorthe Raben, Ann Kathleen Sullivan, Amanda Mocroft, Galyna Kutsyna, Vesna Hadžiosmanović, Anna Vassilenko, Nikoloz Chkhartisvili, Viktar Mitsura, Court Pedersen, Jane Anderson, Josip Begovac, Ulrik Bak Dragsted, Barbara Bertisch, Anna Grzeszczuk, Jane Minton, Valentina Coca Necsoi, Maria Kitchen, Faiza Ajana, Anton Sokhan, Laura Comi, Paymaneh Farazmand, Dragica Pesut, Stephane De Wit, José Maria Gatell, Brian Gazzard, Antonella d'Arminio Monforte, Jürgen Kurt Rockstroh, Yazdan Yazdanpanah, Karen Champenois, Marie Louise Jakobsen, Jens Dilling Lundgren, HIDES Study Group
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220108 (2019)
BackgroundIt is cost-effective to perform an HIV test in people with specific indicator conditions (IC) with an undiagnosed HIV prevalence of at least 0.1%. Our aim was to determine the HIV prevalence for 14 different conditions across 20 European co
Externí odkaz:
https://doaj.org/article/bf7823be76fc42f6968d781cb3c12f31
Autor:
Mark A Boyd, Amanda Mocroft, Lene Ryom, Antonella d'Arminio Monforte, Caroline Sabin, Wafaa M El-Sadr, Camilla Ingrid Hatleberg, Stephane De Wit, Rainer Weber, Eric Fontas, Andrew Phillips, Fabrice Bonnet, Peter Reiss, Jens Lundgren, Matthew Law
Publikováno v:
PLoS Medicine, Vol 14, Iss 11, p e1002424 (2017)
The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study has developed predictive risk scores for cardiovascular disease (CVD) and chronic kidney disease (CKD, defined as confirmed estimated glomerular filtration rate [eGFR] ≤ 60 ml/mi
Externí odkaz:
https://doaj.org/article/05b2995d49c2447ea5aa0bfcbcf6ab75
Autor:
Ward De Spiegelaere, Jan Philippé, Karen Vervisch, Chris Verhofstede, Eva Malatinkova, Maja Kiselinova, Wim Trypsteen, Pawel Bonczkowski, Dirk Vogelaers, Steven Callens, Jean Ruelle, Kabamba Kabeya, Stephane De Wit, Petra Van Acker, Vicky Van Sandt, Marie-Paule Emonds, Paul Coucke, Erica Sermijn, Linos Vandekerckhove
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123525 (2015)
Abacavir is a nucleoside reverse transcriptase inhibitor used as part of combination antiretroviral therapy in HIV-1-infected patients. Because this drug can cause a hypersensitivity reaction that is correlated with the presence of the HLA-B*57:01 al
Externí odkaz:
https://doaj.org/article/e34e992d508a4e7ca2e338a8729d4f0b
Autor:
Daniel A Duprez, Jacqueline Neuhaus, Lewis H Kuller, Russell Tracy, Waldo Belloso, Stephane De Wit, Fraser Drummond, H Clifford Lane, Bruno Ledergerber, Jens Lundgren, Daniel Nixon, Nicholas I Paton, Ronald J Prineas, James D Neaton, INSIGHT SMART Study Group
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44454 (2012)
The SMART study was a trial of intermittent use of antiretroviral therapy (ART) (drug conservation [DC]) versus continuous use of ART (viral suppression [VS]) as a strategy to reduce toxicities, including cardiovascular disease (CVD) risk. We studied
Externí odkaz:
https://doaj.org/article/4c06cf56e36240d6857d0ea32d325528